Amylyx Pharmaceuticals, Inc. (AMLX) Net income 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$144.7MFY2025 · since FY2021: -$87.9M → -$144.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$144.7M | +52.0% |
| FY2024 | -$301.7M | -712.4% |
| FY2023 | $49.3M | +124.8% |
| FY2022 | -$198.4M | -125.6% |
| FY2021 | -$87.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice